Navigation Links
Effective Rx thwarted for deadly opiate epidemic
Date:6/17/2013

WASHINGTON, June 17, 2013 /PRNewswire-USNewswire/ -- The American Society of Addiction Medicine (ASAM) will release the most comprehensive report on the effectiveness of medications for opioid addiction and on the arbitrary restrictions on these FDA-approved drugs by many state governments and insurance companies. Drug overdoses now kill more Americans than drunk driving car crashes, an epidemic led by misuse of opioid pain medication and use of heroin. Yet, safe and effective medications to treat opioid addiction are seriously under-utilized, resulting in preventable suffering and death. "This report will show how we could be saving lives and effectively treating the disease of addiction if state governments and insurance companies remove roadblocks to the use of effective, FDA-approved medications," said Stuart Gitlow, MD, President of ASAM.

The report will be released at a press event at 10:30 a.m., Thursday, June 20, at The National Press Club, 529 14th St NW, Washington, 20045.

Speakers include:

  • Stuart Gitlow, MD, President of ASAM
  • Tom McLellan, PhD, Executive Director of Treatment Research Institute, former Deputy Director of the White House Office of National Drug Control Policy
  • Whitney, opioid addiction patient and expectant mother taking buprenorphine, an FDA-approved addiction medication
  • Michael Botticelli, Deputy Director of the White House Office of National Drug Control Policy

The American Society of Addiction Medicine is a national medical specialty society of over 3,000 physicians. Its mission is to increase access to and improve the quality of addiction treatment, to educate physicians, and other health care providers and the public, to support research and prevention, to promote the appropriate role of the physician in the care of patients with addictive disorders, and to establish Addiction Medicine as a specialty recognized by professional organizations, governments, physicians, purchasers and consumers of health care services and the general public. ASAM was founded in 1954, and has had a seat in the American Medical Association House of Delegates since 1988.

Media Contact:
ALEXIS GEIER HORAN, 202-276-7873, ageier@asam.org


'/>"/>
SOURCE American Society of Addiction Medicine
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Daily 10 milligram dose of S-equol reduces menopausal symptoms effectively without impacting thyroid and sex hormones
2. Aetna, Cardinal Health Specialty Solutions Alliance Delivers More Cost-Effective, Patient-Centered Cancer Care
3. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
4. BioElectronics Continues FDA Clearance Campaign to Bring Chronic Pain Sufferers Safe, Effective, Inexpensive, Drug-Free Pain Therapy
5. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
6. Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness
7. The MED Group Announces New Agreement with CareCentrix Effective May 1, 2013
8. Organogenesis to Present Large Retrospective Comparative Effectiveness Analysis and Health Economic Data in Chronic Wound Healing at The Symposium on Advanced Wound Care and Wound Healing Society Meeting
9. Deploying an Effective Pay for Performance Bonus System that Works Across Multiple Industry Sectors
10. New CDC Study Confirms Effectiveness of UV-C Disinfection in Reducing Harmful Pathogens for Hospitals
11. Varicella Vaccine has Long-Term Effectiveness Against Chicken Pox
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):